Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 24, 2018 08:30 ET | Source: Moleculin Biotech, Inc.

Moleculin Invited to Present to International BioForum 2018 Conference

HOUSTON, May 24, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug...
May 16, 2018 08:30 ET | Source: Moleculin Biotech, Inc.

Moleculin to Begin Clinical Trials at UMC Southwest Cancer Center

HOUSTON, May 16, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug...
May 15, 2018 08:30 ET | Source: Moleculin Biotech, Inc.

Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2018

HOUSTON, May 15, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug...
May 03, 2018 08:30 ET | Source: Moleculin Biotech, Inc.

Moleculin Announces Engagement with Voisin Consulting Life Sciences to Expand Annamycin Clinical Trial

HOUSTON, May 03, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug...